WO2003072731A3 - Particules chimeres hbc stabilisees ayant des immunogenes meningoques - Google Patents
Particules chimeres hbc stabilisees ayant des immunogenes meningoques Download PDFInfo
- Publication number
- WO2003072731A3 WO2003072731A3 PCT/US2003/005499 US0305499W WO03072731A3 WO 2003072731 A3 WO2003072731 A3 WO 2003072731A3 US 0305499 W US0305499 W US 0305499W WO 03072731 A3 WO03072731 A3 WO 03072731A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- meningococcal
- meningoccocal
- immunogens
- hbc chimer
- hbc
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003215395A AU2003215395A1 (en) | 2002-02-21 | 2003-02-21 | STABILIZED HBc CHIMER PARTICLES HAVING MENINGOCCOCAL IMMUNOGENS |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35861802P | 2002-02-21 | 2002-02-21 | |
US60/358,618 | 2002-02-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003072731A2 WO2003072731A2 (fr) | 2003-09-04 |
WO2003072731A3 true WO2003072731A3 (fr) | 2005-02-10 |
Family
ID=27765969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/005499 WO2003072731A2 (fr) | 2002-02-21 | 2003-02-21 | Particules chimeres hbc stabilisees ayant des immunogenes meningoques |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003215395A1 (fr) |
WO (1) | WO2003072731A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883169B2 (en) | 2007-08-16 | 2014-11-11 | Chrontech Pharma Ab | Immunogen platform |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2059256T3 (pl) | 2006-08-11 | 2017-02-28 | Life Sciences Research Partners Vzw | Immunogenne peptydy i ich zastosowanie w zaburzeniach immunologicznych |
CA2715611C (fr) | 2008-02-14 | 2018-03-13 | Life Sciences Research Partners Vzw | Immunotherapie ciblant des agents pathogenes intracellulaires |
ES2676630T3 (es) | 2008-02-14 | 2018-07-23 | Life Sciences Research Partners Vzw | Control inmunogénico de tumores y células tumorales |
JP5667062B2 (ja) | 2008-10-10 | 2015-02-12 | エラ、ビオテック、ソシエダッド、アノニマEra Biotech, S.A. | 免疫原特異的アジュバントとしての組換えタンパク粒 |
EP2418284A1 (fr) | 2010-08-13 | 2012-02-15 | ERA Biotech, S.A. | Séquences de polypeptides induisant le corps protéiques |
ES2924027T3 (es) | 2010-11-25 | 2022-10-04 | Imcyse Sa | Péptidos inmunogénicos para su uso en la prevención y/o tratamiento de enfermedades infecciosas, enfermedades autoinmunitarias, respuestas inmunitarias a alofactores, enfermedades alérgicas, tumores, rechazo de injerto y respuestas inmunitarias contra vectores virales usados para terapia génica o vacunación génica |
GB201201511D0 (en) * | 2012-01-30 | 2012-03-14 | Univ Leuven Kath | Modified epitopes for boosting CD4+ T-cell responses |
GB201309469D0 (en) | 2013-05-28 | 2013-07-10 | Imcyse Sa | Detection of CD4+ T lymphocytes |
GB201418433D0 (en) | 2014-10-17 | 2014-12-03 | Imcyse Sa | Novel immunogenic peptides |
US10729791B2 (en) | 2015-05-18 | 2020-08-04 | Imcyse Sa | Animal models for evaluating pharmaceutical compounds |
CA2995771A1 (fr) | 2015-09-25 | 2017-03-30 | Imcyse Sa | Procedes et composes ameliores pour supprimer des reponses immunitaires a des agents therapeutiques |
KR20220132023A (ko) | 2016-04-19 | 2022-09-29 | 임시스 에스에이 | 신규 면역원성 CD1d 결합 펩티드 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0399743A1 (fr) * | 1989-05-25 | 1990-11-28 | Beecham Group Plc | Dérivées de phosphonométhylthio-alkoxypurines, produits intermédiaires pour leurs préparation et composition pharmaceutiques les contenants |
WO1999040934A1 (fr) * | 1998-02-12 | 1999-08-19 | Immune Complex, Corporation | Proteines noyaux de l'hepatite b strategiquement modifiees et leurs derives |
WO2001098333A2 (fr) * | 2000-06-22 | 2001-12-27 | Celltech Pharmaceuticals Limited | Modification de l'antigene capsidique de l'hepatite b |
-
2003
- 2003-02-21 AU AU2003215395A patent/AU2003215395A1/en not_active Abandoned
- 2003-02-21 WO PCT/US2003/005499 patent/WO2003072731A2/fr not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0399743A1 (fr) * | 1989-05-25 | 1990-11-28 | Beecham Group Plc | Dérivées de phosphonométhylthio-alkoxypurines, produits intermédiaires pour leurs préparation et composition pharmaceutiques les contenants |
WO1999040934A1 (fr) * | 1998-02-12 | 1999-08-19 | Immune Complex, Corporation | Proteines noyaux de l'hepatite b strategiquement modifiees et leurs derives |
WO2001098333A2 (fr) * | 2000-06-22 | 2001-12-27 | Celltech Pharmaceuticals Limited | Modification de l'antigene capsidique de l'hepatite b |
Non-Patent Citations (7)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8883169B2 (en) | 2007-08-16 | 2014-11-11 | Chrontech Pharma Ab | Immunogen platform |
Also Published As
Publication number | Publication date |
---|---|
AU2003215395A8 (en) | 2003-09-09 |
WO2003072731A2 (fr) | 2003-09-04 |
AU2003215395A1 (en) | 2003-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002013765A3 (fr) | Immunogene et vaccin antipaludeens | |
WO2005055957A3 (fr) | Immunogene et vaccin contre la grippe | |
WO2002014478A3 (fr) | Particules chimeriques immunogenes de hbc presentant une stabilite amelioree | |
WO2003072731A3 (fr) | Particules chimeres hbc stabilisees ayant des immunogenes meningoques | |
WO2004075836A3 (fr) | Particules chimeriques de hbc stabilisees en tant que vaccins therapeutique pour l'hepatite chronique | |
JP2005270111A (ja) | パピローマウイルス様粒子、融合タンパク質並びにそれらの製造方法 | |
EP0992580A3 (fr) | Epitopes de lymphocytes T humains immunodominants du virus de l'hépatite C | |
WO2001098333A3 (fr) | Modification de l'antigene capsidique de l'hepatite b | |
WO1993000365A3 (fr) | Polypeptides utilises dans la lutte contre le virus de l'hepatite c | |
EP0271302A3 (fr) | Epitopes de la protéine de la nucléocapside du virus de l'hépatite B, pour cellules T | |
WO2004053091A3 (fr) | Particules stabilisees de chimeres de hbc immunogenes | |
HK1081207A1 (en) | Hbv precore protein capable of forming particles | |
WO2004048402A3 (fr) | Gene de fusion ns3/4a non structurel a codons optimises du virus de l'hepatite c | |
WO1999050424A3 (fr) | Preparation et utilisation d'antigenes | |
WO2003102165A3 (fr) | Particules chimeriques hbc immunogenes stabilisees avec une cysteine d'extremite n-termnale | |
SI1506222T1 (sl) | Himerni L1-proteini humanega papilomavirusa 16, ki obsegajo L2-peptid, delci, podobni virusu, pripravljeni iz njih, in postopek za pripravo delcev | |
EP0572737A3 (fr) | Antigène fusion gag-env de HIV. | |
WO2001070262A3 (fr) | Procede servant a generer des immunogenes elicitant des anticorps de neutralisation contre des zones de fusion active de proteines d'enveloppe de vih | |
EP0199480A3 (en) | Hepatitis a virus vaccines | |
WO2002088339A3 (fr) | Particules pseudovirales de birnavirus | |
WO1997039029A3 (fr) | Epitope antigenique du determinant a de l'antigene de surface de l'hepatite b et ses utilisations | |
WO2003072722A3 (fr) | Particules chimeres de la proteine capsidique de l'hepatite b aviaire immunogenique a stabilite amelioree | |
AU2001286669A1 (en) | Oral fluid rapid assay for hepatitis c virus (hcv) antibodies using non-antibody labeling of iga molecules recognizing hcv peptide epitopes | |
IL160286A0 (en) | Angiotensin peptide-carrier conjugates and uses thereof | |
WO2002026943A3 (fr) | Production de particules pseudovirales de vhc en cellules d'insectes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |